Home / Transcripts / Emami Limited (531162) · November 5, 2026

Emami Limited (531162) Earnings Call Transcript

November 5, 2026

BSE Limited IN Consumer Staples Personal Care Products earnings 31 min

Earnings Call Speaker Segments

Operator operator
#1

Good day, ladies and gentlemen, and welcome to the Emami Limited Q2 FY '27 earnings conference call, which IIFL Capital Services Limited is hosting. <<operator_script>> Kindly be aware that this conference is being recorded. At this point, I hand the conference over to Mr. Siddhesh Deshmukh of IIFL Capital Services Limited. Thank you, and over to you, sir.

Siddhesh Deshmukh analyst
#2

Good afternoon, everyone. It's my pleasure to welcome the management team from Emami Limited to our 2Q FY '27 earnings call. Joining us from the management side are Mr. Mohan Goenka, Whole Time Director and Vice Chairman; Mr. Vivek Dhir, CEO of the International Business; Mr. Dhruv Aggarwal, Chief Growth Officer; Mr. Gul Raj Bhatia, President of Healthcare; Mr. Manish Gupta, President of Sales; and Mr. Rajesh Sharma, President of Finance and IR. I'll now turn the call over to Mr. Mohan Goenka for his opening remarks, and after that we'll open the floor for Q&A. Over to you, sir.

Mohan Goenka executive
#3

Good afternoon, ladies and gentlemen. Thanks for being with us today for Emami Limited's Q2 ' 27 Earnings Call. Continuing the strong momentum we saw in Q1, this quarter was another one of broad-based, strong double-digit growth, with our core brands and strategic investments both doing well. Let me take you through the quarter's highlights. Consolidated revenue rose 36% to INR 1,088 crores. Domestic sales were up 49%, helped by volume growth of 43%. On a like-to-like basis, taking into account the previous period's revenue from Axiom and IncNut Digital, consolidated sales rose 24%, and the Domestic Business grew 32%, with volume growth of 26%. By category, Skin Care was up 31%. That was driven by robust growth in our Talc portfolio, which more than doubled in the quarter. BoroPlus grew in near 20s, and Smart & Handsome delivered double-digit growth. Hair & Scalp Care rose 30% during the quarter. Navratna Oil grew in the 30s, and Kesh King grew in high teens. We also launched the Kesh King Scalp First range in modern trade and e-com. And I must mention 7 Oils in One, which carried on its remarkable run and almost doubled its sales this quarter.

Mohan Goenka executive
#4

At present, this is among the quickest-expanding labels within our main portfolio. The Healthcare line rose 11%, while the Pain Management line expanded at a rate in the teens. The OTC portfolio likewise turned in a solid showing, with growth in the high teens. The Medico line delivered steady single-digit expansion. Turning now to the strategic investments portfolio. On a like-to-like basis, we achieved an impressive 73% increase, and it accounted for roughly 26% of our domestic business. Sales at Axiom and Brillare were more than double what they were before. IncNut posted growth of over 50%, and The Man Company of over 30%. We broadened Axiom's presence in modern trade chains and quick com, and we put investment into building visibility for the AloFrut brand. At IncNut, we are now extending beyond D2C into marketplaces. Operations on quick com have begun, and we have also made our entry into new international markets. When I take a step back and consider all of this as a whole, our core portfolio and our strategic investments are both performing strongly, and they are doing so alongside each other. We are purposefully constructing a more diversified business — one that covers, first, traditional FMCG, personal and health care; and second, premium beauty and grooming, digital-first brands and emerging consumer platforms. Such diversification accomplishes 2 things. It broadens our growth runway, and it renders the business more resilient through differing economic and consumption cycles.

Mohan Goenka executive
#5

The shift in our channel strategy is progressing at a stable rate. Organized channels are now responsible for 37% of our domestic business. Both modern trade and e-com kept up strong momentum, and quick com represents roughly 15% of our digital sales at this point. That's a meaningful change in the way consumers are picking to shop with us. Turning to our international business, Q2 performance took a hit from a few particular external disruptions, with revenue falling by 2%. Importantly, the softness was not widespread. Severe floods affected Nepal. And Gulf markets are still dealing with supply chain challenges stemming from ongoing regional conflicts. Leaving out Nepal and Iraq, our international business posted growth of 6%. Inflationary pressures stayed elevated throughout the quarter, and the steep increase in input costs weighed on our margins -- weighted on our margins. Along with the shifting business mix that followed the integration of the acquired business, this led to higher COGS and a gross margin decline of 520 basis points versus last year. Even with these pressures, EBITDA rose by 25% to INR 222 crores and profit before tax climbed by 29% to INR 194 crores. I believe this shows the resilience of our business model and how effective the cost management initiatives were that our teams carried out during the quarter.

Mohan Goenka executive
#6

Profit after tax came in at INR 144 crores, a decline of 3%, and this is mostly because our effective tax rate has normalized after fiscal benefits were phased out. Turning to the first half of FY '27, revenue reached INR 2,127 crores, a rise of 25%. EBITDA came to INR 449 crores, up 15%, and profit before tax was INR 388 crores, an increase of 15%. On capital allocation, last month we finished our share buyback of INR 281 crores, repurchasing 73 lakh shares. The Board has additionally approved a first interim dividend of INR 5 per share, amounting to a payout of INR 214 crores. Looking forward, we continue to feel very optimistic regarding the business's growth prospects. We take encouragement from the strong showing of our core brands, the swift scaling of our digital-first brands and continued traction in modern trade, e-com and quick com. Commodity inflation and geopolitical developments are still areas to watch. Still, our diversified portfolio, strengthened distribution, robust innovation pipeline and disciplined cost management leave us well positioned to deliver sustained profitable growth over the rest of FY '27. With that, I would now like to open the floor for questions.

Mohan Goenka executive
#7

Thanks.

Operator operator
#8

<<operator_script>> Our first question comes from Abneesh Roy at Nuvama.

Abneesh Roy analyst
#9

Thanks — those are really strong results. First off, I've got a question about the new launches, and there are quite a few of them. For now, though, I'd like to hone in on just 2. Specifically the Maa range and the Kesh King Scalp First range — with both of these, it feels like you've come in a bit later than others. So could you walk us through how your pricing compares with the established, strong competitors in each of those segments? Also, you've attempted premium personal care before as well. So what lessons came out of that? What's different in your approach now? And how did that earlier premium personal care effort perform in terms of success? If you could touch on that too, that would be great. That's my first question.

Mohan Goenka executive
#10

Okay, Abneesh, regarding the baby care range, we're of course testing it out — starting with e-commerce and modern trade. What sets us apart is that our pricing isn't as high as other products on the market. It's roughly 25% to 50% less expensive, depending on which product range you look at, alright? So we're really targeting a mass-market audience compared with some of the others. The market size is roughly INR 30,000 crores to INR 40,000 crores, okay? And since BoroPlus is purely Ayurveda, we've launched it under the BoroPlus brand. So we'll give it a try. Naturally, we're calling out certain ingredients such as special almonds, kashmiri kesar, whatever the ingredients happen to be. So let's see how it goes. I believe we're well positioned when it comes to price as well as e-commerce and quick commerce. After that, of course, it would hinge on the market. But this time around, we're going to place somewhat more emphasis on the baby care range. And Kesh King Scalp First is, once again, another — we were looking to extend the Kesh King brand. This time it's a premium offering, priced roughly in the INR 500 to INR 1,000 range.

Mohan Goenka executive
#11

Let's see. Once again, at this point we have a solid foothold in e-commerce and quick commerce through our other products. So with those relationships, we get how that market operates. And in the case of Kesh King, this is therefore a fresh entry. We do want to move the Kesh King brand somewhat in the premium direction, yes.

Abneesh Roy analyst
#12

Let me ask one more thing about the Kesh King First Scalp. Naturally, at that price point, hard science is going to work. So is your main focus treating this as a brand extension? Or is there a genuine consumer need being met here that will demand hardcore R&D? What I wanted to ask is whether there's anything on the product side that truly sets it apart beyond, let's say, the very good packaging, the very good brand extension, and so on. Is there anything disruptive when it comes to the product formulation?

Mohan Goenka executive
#13

Yes, definitely. And really, we're leaning quite a lot on the R&D side of things, because if you look closely at what's in it, there are certain ingredients that are unique. We're referring to it as detoxifying scalp and <<inaudible>>, or something along those lines. So basically -- we're depending heavily on R&D. Consumers have grown very savvy. These days they check the levels. And on these platforms, we're also going to emphasize the ingredient aspect. That's the reason they carry such a big premium.

Abneesh Roy analyst
#14

Got it — last question, on the strategic investment, congratulations, really strong numbers there...

Mohan Goenka executive
#15

But naturally, they cost far less than L'Oreal or those other brands, Derma Co and Pilgrim. They still sit at the lower end of that range.

Abneesh Roy analyst
#16

Got it — last question on strategic investment, Mohanji. So here, there's a 5% acceleration quarter-on-quarter. If you could discuss the profitability side, clearly, these are currently in the gestation phase. I wanted to understand, is there any improvement on the profit metrics versus Q1? And on the four brands, you did give out the revenue growth numbers specifically. But where is the confidence level higher from a medium, long term on those four subsegments within the strategy? Where is the highest confidence you are getting this year, of course, being first year of relaunch or some of them are new, growth rates are very, very robust. I don't think that may give us the full picture. I wanted to understand from your own initial targets versus what you are getting, where is the confidence level higher?

Mohan Goenka executive
#17

Yes, Dhruv is present, so I'll hand things over to him for the answer. But Abneesh, these aren't new brands — they've been available in the market for a good while now, and we've been <<inaudible>> it over.

Abneesh Roy analyst
#18

Right, so quite a bit of relaunching has taken place — Man Company and all of that.

Mohan Goenka executive
#19

Yeah, yeah. So Dhruv's going to take that one.

Dhruv Aggarwal executive
#20

I believe we're up 5% compared with the H1 figure, though on an overall basis against Q1 we're actually up 12%. If my memory serves me right, Q1 stood at 51% growth. The reason — if you were to ask which of these I feel a great deal of confidence in, I have a plan for — or rather we have a plan for all 4 of them, correct? So whether it's Brillare, TMC, Axiom or IncNut. For all 4, the levers differ, and they differ very, very substantially from one another. TMC was one where things had gone a bit stagnant, we got it moving to high 20% margins, and this quarter it's up 30% plus. So our confidence that those plans are working is very strong. It comes down to reformulation, ensuring we offer customers the best possible products, and then marketing that matches how consumers are viewing <<inaudible>> for a few of the other brands; that's simply a very different collection of initiatives across the board, and I see no reason we can't keep this growth going. For growth of this kind to happen, I think everything has to fire.

Dhruv Aggarwal executive
#21

Even if a single brand declines, you won’t be seeing figures like these. So <<inaudible>>, will we keep seeing 70%? Probably not, but there will definitely be strong growth there across all four.

Mohan Goenka executive
#22

Abneesh, quite a bit is going on. Sure, as Dhruv mentioned, 70% is aggressive figures, yet we're bringing on plenty of fresh talent at the same time, and a great deal of R&D effort is being poured into — a number of these products will be arriving in — certain products are set to launch in GT. So big ambitions lie ahead across all four product ranges.

Operator operator
#23

Moving on, we have a question from Harit Kapoor at Investec.

Harit Kapoor analyst
#24

There's just one question I had, and it's on the profitability side. Obviously, to support the growth, and since new brands typically carry higher A&P spend, we've seen the A&P ratios come in a tad higher — not too much higher, actually. I just wanted to understand whether we should see this broad ratio, which was around 20% last year — should we assume that structurally it's a bit higher over the next 2 years, as we look not only to get the B2C brands up and running at a good pace but also, at an organic level, you seem to be adding significantly to the portfolio. So I just wanted some color on the A&P-to-sales thought — where should this land over the next 2 years, given that you're in a significant investment phase.

Mohan Goenka executive
#25

Harit, we're clearly in spending mode right now, since our priority has been top-line growth. After a great many quarters, our domestic business — especially the core portfolio — is really firing, along with a great many brands. So at this moment, we're not sitting here thinking about 0.5% or 1% here and there. Wherever opportunities show up, we want to put money into advertising. That said, I think you should factor in a range of 18% to 19% at most for A&P spending across the whole year — for the full year.

Harit Kapoor analyst
#26

The second part concerned the core portfolio — though honestly, everything counts as core when it comes to India. Two things I hoped to clarify. First, how large were the price hikes you needed in order to counter inflation at this level? And will some of that show up during the coming quarters? Second, on rural: could you give a sense — I realize your channel mix is shifting and rural's importance may be declining. Still, I'd like your view of the rural outlook and what you're observing on the ground, including in Q2 and during October. That's against the backdrop of inflation, a rainfall deficit, and so forth. Are there pockets where you're noticing a bit of volatility? Those are my 2 questions.

Mohan Goenka executive
#27

Regarding price increases, Harit, the figure came in at 5.5% across the full year. Every cost hike that occurred, we have passed it straight through to consumers, no question. That said, on the rural side, certain markets — especially in the South and West, where rainfall was notably lower and drought-like conditions appeared — those rural markets did not do so well, particularly for a few of our brands. Still, broadly speaking, some pockets of UP also underperformed. Yet many districts did very, very well, where rainfall was good. So it has been a mixed bag, but we are now heading into peak season for winter. After Diwali, I think things should pick up now.

Operator operator
#28

We now go to Arnab Mitra with Goldman Sachs for the next question.

Arnab Mitra analyst
#29

Mohanji, congratulations on a very strong quarter. My first question was on the core business. If I look at the first half, I know this quarter had a slightly low base because of the GST-related issues last year. If you look at the first half growth of the core business, how do you think of the second half growth? Because there has been a lot of shifts of timing of festivity. There is also the GST upstock, destock. So generally, as we look at for second half versus first half, what's your sense of how the core business could be doing?

Mohan Goenka executive
#30

So, Arnab, the momentum is carrying forward, in our view. And for the second half, we expect growth in this business of somewhere between 18% and 20%.

Arnab Mitra analyst
#31

Understood — so that's the total, and...

Mohan Goenka executive
#32

Yeah, altogether. All of it combined. That's right.

Arnab Mitra analyst
#33

Got it. And Mohanji, on the international business, the drop was smaller this quarter. Still, though, with the supply chain changes and everything, could you update us on where things stand right now and, on that basis, what you expect?

Mohan Goenka executive
#34

Yes, so Vivek — our international CEO — is over there. Vivek, could you shed some light on that?

Vivek Dhir executive
#35

Based. Only in, say, a couple of geographies did we fail to achieve growth there. But across most other locations, we've expanded. So as you look at the months ahead, over the last 2, 3 months, growth is being seen in a great many places. We've essentially turned the business around in Bangladesh and the GCC because of the OTC hazardous goods, which accounts for roughly 2% of our business and remains on hold. We cannot get those goods moved from India to other locations. So for us that continues to be an unresolved issue. Apart from that, however, we're now progressing with growth in nearly every geography. So I think the worst is behind us internationally.

Mohan Goenka executive
#36

And Arnab, about October — Vivek, please jump in if I get this wrong, but my understanding is that October was a positive month for the international business.

Vivek Dhir executive
#37

Correct, sir — it was in the high double digits, that's right.

Mohan Goenka executive
#38

Yeah, so Arnab, I think at this point we're on that growth path.

Arnab Mitra analyst
#39

Understood. My final question concerns margins. Looking at how gross margin was affected this quarter — roughly a 500 basis point rise in what we pay for raw materials — how much of that, Mohanji, would you call fundamental, given the shift in our mix toward the newer categories? And how much comes from input cost inflation, where, say, between pricing and a fall in crude, do you believe we could recover it?

Mohan Goenka executive
#40

Arnab, of that nearly 550 basis points, 400 basis points came purely from RM cost, and the rest was mix. That said, Arnab, I'm quite confident that once we get past this — the second half will come in higher, since we've now procured at these prices. But looking ahead, I think we ought to gain from these input corrections, and that will apply to next year.

Operator operator
#41

Our next question comes from Rahul at Bowhead.

Rahul Jha analyst
#42

Nice work on those results, Mohanji. My question is this: when quarter 1 wrapped up, you'd guided to roughly INR 750 crores to INR 800 crores for strategic investment. This quarter we've come in at a run rate of about INR 240 crores. So is there room, in your view, to raise that guidance?

Mohan Goenka executive
#43

Yes. Dhruv, would you care to shed some light on that?

Dhruv Aggarwal executive
#44

We will definitely hit INR 800 crores plus this year.

Mohan Goenka executive
#45

Yeah, that should stay at INR 850 crores. <<foreign_lang>> If you treat that as the run rate, it comes out to roughly INR 1,000 crores to INR 1,100 crores.

Rahul Jha analyst
#46

Okay, sir, on the international side — sir, actually Dabur came out with results yesterday, and they posted double-digit growth in the Middle East along with 33% in Bangladesh. So does our supply chain work quite differently from what Dabur is doing in those countries?

Vivek Dhir executive
#47

Dabur has roughly 11 production sites outside India, spread across various locations. The geographic mix, I think, is fairly distinct. Our overlap really only occurs in the GCC, and in Bangladesh as well. Inflation has been felt pretty much everywhere, and we've managed to implement price hikes and the resulting reductions in schemes. But in most of the markets where I look at our presence — Russia, Ukraine — that's another troubled region, yet it's growing for us. Likewise the GCC, and in those same markets such as Hormuz, like Iraq, which took quite a hit for me in quarter 2, with almost 0 sales. We couldn't move goods into Iraq at all; we've now identified alternative routes and are shipping to Port Aqaba. And those kinds of constraints don't apply to those companies. They operate in the U.S., they operate in Africa — South Africa, Nigeria — and they have manufacturing sites there. So our manufacturing footprint is limited to India, Bangladesh, UAE, and around Germany. And on top of that, we also have toll manufacturing in Thailand, but the goods still need to reach the markets where we do business. So even the Black Sea route to Russia and other matters were disrupted during the quarter, and other companies don't encounter those kinds of problems.

Vivek Dhir executive
#48

The issues that Dabur, or perhaps Godrej or Marico, would list are likely to differ from the ones we're dealing with.

Operator operator
#49

<<operator_script>> Our following question comes from Saksham Tyagi, calling in from Desvelado Advisory.

Saksham Tyagi analyst
#50

My question is this, sir: on the last conference call, you said a data analytics and AI platform was being built. So I was hoping for an update — I'd just like to hear how far along that work is at this point. And once it's finished, what impact will it have?

Mohan Goenka executive
#51

Right. So Manish is heading up this AI…

Manish Gupta executive
#52

Saksham, would you mind asking that again? I wasn't able to catch it clearly.

Saksham Tyagi analyst
#53

Yes, sir. On the last call, you said you were building a data analytics and AI platform. So I just wanted to ask what progress has been made so far, and once that work is finished, what the impact will be, with respect to AI, data, and all of that?

Manish Gupta executive
#54

Okay, so things are moving along as planned. Actually, we're slightly ahead of schedule, and that makes us happy. What we're really doing is digitizing and applying AI across our end-to-end processes, all the way from forecasting through to fulfillment. So every part of our operation—whether that's the supply chain in between, invoicing, or the distributor-led frontline booking—all of these processes are being overhauled with new technology, new tools, and putting AI to work. I'd say the progress we're seeing is excellent, and more results will arrive over the coming quarters as we finish these transitions.

Saksham Tyagi analyst
#55

Do you have any sort of time line for that?

Manish Gupta executive
#56

We anticipate being able to wrap this up during the upcoming quarter. So starting in April, we ought to begin witnessing genuine improvements. In the pilot stages we've already run in certain markets, we're achieving some quite striking outcomes.

Saksham Tyagi analyst
#57

Alright, sir, I understand, sir. My second question concerns growth. International business fell almost 7% year over year, so what is your plan to get that growth rate back into positive territory? And when might we realistically see some improvement there?

Vivek Dhir executive
#58

On the international side, business has already turned positive. Looking at August, September, and October, we're seeing improvement. During the early months, while things were being realigned, we did lose some business. One portion of my business that isn't present with any other company involves OTC goods—specifically Pain Management—which does move. Part of that falls under the hazardous category because of the spray and gaseous-form products. That movement remains restricted, and right now we can't get goods out of India. This portion accounts for approximately 2% of my global business—the part I'm unable to ship out. So that continues to create pressure as well, but we've been in positive territory for 3 months now.

Saksham Tyagi analyst
#59

All right. So on a quarter-on-quarter basis, we're profitable, correct?

Operator operator
#60

That brings this conference to a close on behalf of IIFL Capital Services Limited and Emami Limited. We appreciate your participation, and you're free to disconnect your lines at this time.

Executive executive
#61

Thanks. Thanks to all of you for being with us today as we go over our Q2 quarterly results. Appreciate it.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Emami Limited transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Emami Limited earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.